Race Oncology Limited Appoints John Cullity as Non-Executive Director, Effective April 6, 2018 Replacing Brendan Dekauwe
April 04, 2018 at 02:27 am
Race Oncology Limited announced the appointment of U.S.-based Dr. John Cullity as a non-executive director for the company. Dr. Cullity has previously held senior executive roles with Sanofi-Aventis and Schering-Plough in the U.S., and he has consulted to the World Health Organization and the World Bank. Dr. Cullity's appointment is effective April 6, 2018 and he replaces Dr. Brendan Dekauwe, who has resigned as a non-executive director of the company.